Studies Confirm Link Between Breast Density and Cancer
WEDNESDAY, April 21 (HealthDay News) — Having dense breasts has long been known to increase a woman’s risk for breast cancer, and new research confirms that a decline in breast density over time does, in fact, decrease that risk.
Read more on HealthDay via Yahoo! News
Breast cancer is the second leading cause of cancer death in women in the United States, with approximately 180,000 cases diagnosed each year. Researchers continue to evaluate environmental factors, such as diet, that influence the development of breast cancer. Numerous studies have provided a wealth of often-contradictory information about the detrimental and protective factors of different foods. High fruit and vegetable consumption has been associated with a reduced risk for developing at least 10 different cancers. Studies evaluating the influence of diet on breast cancer prognosis have produced inconsistent results.
Researchers from California and Utah assessed a cohort of 1,901 women from the Life After Cancer Epidemiology (LACE) Study who were diagnosed with early-stage breast cancer between 1997 and 2000. Upon entering the study, the women completed a food frequency questionnaire (FFQ). The researchers used the data from the FFQs to identify two dietary patterns among the women: a prudent diet included high intakes of fruits, vegetables, whole grains, and poultry, whereas a Western diet included high intakes of red and processed meats and refined grains. The researchers then evaluated the rates of recurrence, overall death, death from breast cancer, and death from causes other than breast cancer. As of May 2008, there were 268 breast cancer recurrences and 226 deaths, 128 of which were attributed to breast cancer.
» Read more: Terramed Alliance News Healthy Diet Can’t Hurt, May Help Breast Cancer Patients
Primitive neuroectodermal tumors (PNETs) arise from undifferentiated brain cells and are the most frequent malignant brain tumors in children. There are different forms of PNETs and, while scientists have made progress in characterizing the genetic abnormalities associated with some PNET subtypes, the highly aggressive cerebral tumors known as CNS-PNETs have been difficult to characterize as they represent a relatively uncommon group of tumors with ill-defined diagnostic features.
“Lack of insight into the molecular pathogenesis of CNS-PNET is a major obstacle towards development of disease-specific models and treatments for these frequently fatal malignancies,” explains senior study author, Dr. Annie Huang from the Hospital for Sick Children in Ontario, Canada. To comprehensively define relevant genetic alterations associated with CNS-PNET, Dr. Huang established international collaborations with colleagues from pediatric oncology centers in Asia, Europe and the United States to complete a sophisticated high resolution genomic screen of a large collection of primary tumors.
» Read more: New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors